1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa In-Vitro Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa In-Vitro Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa In-Vitro Diagnostics Market Regional Analysis
6.2 Middle East & Africa In-Vitro Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa In-Vitro Diagnostics Market Forecast Analysis
7. Middle East & Africa In-Vitro Diagnostics Market Analysis – by Product & Services
7.1 Reagents & Kits
- 7.1.1 Overview
- 7.1.2 Reagents & Kits: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Software & Services
- 7.3.1 Overview
- 7.3.2 Software & Services: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa In-Vitro Diagnostics Market Analysis – by Technology
8.1 Immunoassay/Immunochemistry
- 8.1.1 Overview
- 8.1.2 Immunoassay/Immunochemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinical Chemistry
- 8.2.1 Overview
- 8.2.2 Clinical Chemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Molecular Diagnostics
- 8.3.1 Overview
- 8.3.2 Molecular Diagnostics: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Microbiology
- 8.4.1 Overview
- 8.4.2 Microbiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Blood Glucose Self-Monitoring
- 8.5.1 Overview
- 8.5.2 Blood Glucose Self-Monitoring: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Coagulation & Hemostasis
- 8.6.1 Overview
- 8.6.2 Coagulation & Hemostasis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Hematology
- 8.7.1 Overview
- 8.7.2 Hematology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Urinalysis
- 8.8.1 Overview
- 8.8.2 Urinalysis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa In-Vitro Diagnostics Market Analysis – by Application
9.1 Infectious Diseases
- 9.1.1 Overview
- 9.1.2 Infectious Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Diabetes: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Oncology
- 9.3.1 Overview
- 9.3.2 Oncology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 Cardiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Nephrology
- 9.6.1 Overview
- 9.6.2 Nephrology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa In-Vitro Diagnostics Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Laboratories
- 10.2.1 Overview
- 10.2.2 Laboratories: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Homecare
- 10.3.1 Overview
- 10.3.2 Homecare: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa In-Vitro Diagnostics Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa In-Vitro Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.1.2 South Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 South Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.1.4 South Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia:
Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by End User
- 11.2.1.3 UAE:
Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.3.2 UAE: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 UAE: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.3.4 UAE: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa In-Vitro Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Danaher Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Siemens AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sysmex Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Becton Dickinson and Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 bioMerieux SA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Qiagen NV
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations